Efficacy of Botulinum Toxin A in Preventing Keloids, Randomized Control Trial Study : Intraindividual subject

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20150811002

Enrollment

Registered

2015-08-11

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound outcome

Interventions

Corticotherapy,Botulinum toxin A

Active Comparator Drug,Active Comparator Drug

kenacort,Botulinum toxin A

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were 1) over 18 years old, 2) having at least 2 sites or one site > 10 cm in length of hypertrophic scars or keloids 3) having unsightly scars that required scar revision or excision, and 4) volunteering to enroll in the study protocol.

Exclusion criteria

Exclusion criteria: The exclusion criteria were 1) allergic to botulinum toxin or xylocaine 2) pregnancy 3) breast feeding 4) received a previous injection of botulinum toxin within 6 months, 5) undesirable medical conditions 6) Taking anticoagulant or antiplatelet

Design outcomes

Primary

Measure	Time frame
vancouver scar scale 6 month Pair T test	—

Secondary

Measure	Time frame
No No No	—

Countries

Thailand

Contacts

Public ContactChatchai Pruksapong

nil

cpruksapong@hotmail.com+66863178962

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Efficacy of Botulinum Toxin A in Preventing Keloids&#44; Randomized Control Trial Study : Intraindividual subject